Regulation and mechanisms of macrophage cholesterol efflux.
暂无分享,去创建一个
[1] I. Björkhem. Do oxysterols control cholesterol homeostasis? , 2002, The Journal of clinical investigation.
[2] M. Freeman,et al. Naturally Occurring Mutations in the Largest Extracellular Loops of ABCA1 Can Disrupt Its Direct Interaction with Apolipoprotein A-I* , 2002, The Journal of Biological Chemistry.
[3] B. McManus,et al. Increased ABCA1 activity protects against atherosclerosis. , 2002, The Journal of clinical investigation.
[4] S. Yokoyama,et al. Helical Apolipoproteins Stabilize ATP-binding Cassette Transporter A1 by Protecting It from Thiol Protease-mediated Degradation* , 2002, The Journal of Biological Chemistry.
[5] T. Willson,et al. Synthetic LXR ligand inhibits the development of atherosclerosis in mice , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[6] W. Fung-Leung,et al. Leukocyte ABCA1 controls susceptibility to atherosclerosis and macrophage recruitment into tissues , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[7] O. Francone,et al. Increased Atherosclerosis in Hyperlipidemic Mice With Inactivation of ABCA1 in Macrophages , 2002, Arteriosclerosis, thrombosis, and vascular biology.
[8] C. Glass,et al. Conditional Disruption of the Peroxisome Proliferator-Activated Receptor γ Gene in Mice Results in Lowered Expression of ABCA1, ABCG1, and apoE in Macrophages and Reduced Cholesterol Efflux , 2002, Molecular and Cellular Biology.
[9] J. Oram,et al. Unsaturated Fatty Acids Inhibit Cholesterol Efflux from Macrophages by Increasing Degradation of ATP-binding Cassette Transporter A1* , 2002, The Journal of Biological Chemistry.
[10] K. Bornfeldt,et al. Cyclic AMP-specific phosphodiesterase 4 inhibitors promote ABCA1 expression and cholesterol efflux. , 2002, Biochemical and biophysical research communications.
[11] A. Zwinderman,et al. Association between increased arterial-wall thickness and impairment in ABCA1-driven cholesterol efflux: an observational study , 2002, The Lancet.
[12] Gaochao Zhou,et al. Dual Mechanisms of ABCA1 Regulation by Geranylgeranyl Pyrophosphate* , 2001, The Journal of Biological Chemistry.
[13] R. F. Hoyt,et al. The ATP binding cassette transporter A1 (ABCA1) modulates the development of aortic atherosclerosis in C57BL/6 and apoE-knockout mice , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[14] A. Tall,et al. Acid Sphingomyelinase-deficient Macrophages Have Defective Cholesterol Trafficking and Efflux* , 2001, The Journal of Biological Chemistry.
[15] Carrie M. Welch,et al. Preferential ATP-binding Cassette Transporter A1-mediated Cholesterol Efflux from Late Endosomes/Lysosomes* , 2001, The Journal of Biological Chemistry.
[16] C. Fielding,et al. Cellular cholesterol efflux. , 2001, Biochimica et biophysica acta.
[17] Gaochao Zhou,et al. 27-Hydroxycholesterol Is an Endogenous Ligand for Liver X Receptor in Cholesterol-loaded Cells* , 2001, The Journal of Biological Chemistry.
[18] H. Brewer,et al. Cellular localization and trafficking of the human ABCA1 transporter. , 2001 .
[19] A. Tall,et al. ATP-binding Cassette Transporter A1 (ABCA1) Functions as a Cholesterol Efflux Regulatory Protein* , 2001, The Journal of Biological Chemistry.
[20] L. Molday,et al. Membrane Topology of the ATP Binding Cassette Transporter ABCR and Its Relationship to ABC1 and Related ABCA Transporters , 2001, The Journal of Biological Chemistry.
[21] J. Cheng,et al. Regulation and Activity of the Human ABCA1 Gene in Transgenic Mice* , 2001, The Journal of Biological Chemistry.
[22] B. Shan,et al. Unsaturated fatty acids inhibit transcription of the sterol regulatory element-binding protein-1c (SREBP-1c) gene by antagonizing ligand-dependent activation of the LXR , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[23] K. Moore,et al. ATP-binding Cassette Transporter A1 Contains an NH2-terminal Signal Anchor Sequence That Translocates the Protein's First Hydrophilic Domain to the Exoplasmic Space* , 2001, The Journal of Biological Chemistry.
[24] S. Kliewer,et al. A selective peroxisome proliferator-activated receptor δ agonist promotes reverse cholesterol transport , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[25] H. Rigneault,et al. Specific Docking of Apolipoprotein A-I at the Cell Surface Requires a Functional ABCA1 Transporter* , 2001, The Journal of Biological Chemistry.
[26] J. Wilcox,et al. Localization of Human ATP-Binding Cassette Transporter 1 (ABC1) in Normal and Atherosclerotic Tissues , 2001, Arteriosclerosis, thrombosis, and vascular biology.
[27] J. Auwerx,et al. Reduction of atherosclerosis in apolipoprotein E knockout mice by activation of the retinoid X receptor , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[28] H. Brewer,et al. Apolipoprotein specificity for lipid efflux by the human ABCAI transporter. , 2001, Biochemical and biophysical research communications.
[29] R. Evans,et al. A PPARγ-LXR-ABCA1 Pathway in Macrophages Is Involved in Cholesterol Efflux and Atherogenesis , 2001 .
[30] H. Brewer,et al. Cellular Localization and Trafficking of the Human ABCA1 Transporter* 210 , 2001, The Journal of Biological Chemistry.
[31] J. Oram,et al. Unsaturated fatty acids inhibit cholesterol efflux from macrophages by increasing degradation of ATP-binding cassette transporter A 1 , 2001 .
[32] R. Evans,et al. A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis. , 2001, Molecular cell.
[33] Jean-Marc A. Lobaccaro,et al. Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRα and LXRβ , 2000 .
[34] R. Lawn,et al. ABCA1 Is the cAMP-inducible Apolipoprotein Receptor That Mediates Cholesterol Secretion from Macrophages* , 2000, The Journal of Biological Chemistry.
[35] A. Tall,et al. Specific Binding of ApoA-I, Enhanced Cholesterol Efflux, and Altered Plasma Membrane Morphology in Cells Expressing ABC1* , 2000, The Journal of Biological Chemistry.
[36] M. Krieger,et al. Scavenger Receptor Class B, Type I-mediated [3H]Cholesterol Efflux to High and Low Density Lipoproteins Is Dependent on Lipoprotein Binding to the Receptor* , 2000, The Journal of Biological Chemistry.
[37] M. Krieger,et al. Binding of High Density Lipoprotein (HDL) and Discoidal Reconstituted HDL to the HDL Receptor Scavenger Receptor Class B Type I* , 2000, Journal of Biological Chemistry.
[38] S. Zuckerman,et al. Interferon-gamma induces downregulation of Tangier disease gene (ATP-binding-cassette transporter 1) in macrophage-derived foam cells. , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[39] I. Shimomura,et al. Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta. , 2000, Genes & development.
[40] Y. Takahashi,et al. Cholesterol efflux to apolipoprotein AI involves endocytosis and resecretion in a calcium-dependent pathway. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[41] M C Phillips,et al. Cell cholesterol efflux: integration of old and new observations provides new insights. , 1999, Journal of lipid research.
[42] T. Langmann,et al. Molecular cloning of the human ATP-binding cassette transporter 1 (hABC1): evidence for sterol-dependent regulation in macrophages. , 1999, Biochemical and biophysical research communications.
[43] K. Williams,et al. The response-to-retention hypothesis of atherogenesis reinforced. , 1998, Current opinion in lipidology.
[44] Yong Ji,et al. Scavenger Receptor BI Promotes High Density Lipoprotein-mediated Cellular Cholesterol Efflux* , 1997, The Journal of Biological Chemistry.
[45] Helen H. Hobbs,et al. Identification of Scavenger Receptor SR-BI as a High Density Lipoprotein Receptor , 1996, Science.
[46] J. Taylor,et al. Macrophage-specific expression of human apolipoprotein E reduces atherosclerosis in hypercholesterolemic apolipoprotein E-null mice. , 1995, The Journal of clinical investigation.
[47] G. Francis,et al. Defective removal of cellular cholesterol and phospholipids by apolipoprotein A-I in Tangier Disease. , 1995, The Journal of clinical investigation.
[48] J. Breslow,et al. Human apolipoprotein A-I gene expression increases high density lipoprotein and suppresses atherosclerosis in the apolipoprotein E-deficient mouse. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[49] R. Krauss,et al. Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI , 1991, Nature.
[50] S. Yokoyama,et al. Interaction of free apolipoproteins with macrophages. Formation of high density lipoprotein-like lipoproteins and reduction of cellular cholesterol. , 1991, The Journal of biological chemistry.
[51] W. J. Johnson,et al. Mechanisms and consequences of cellular cholesterol exchange and transfer. , 1987, Biochimica et biophysica acta.
[52] J. Albers,et al. The effects of subfractions of high density lipoprotein on cholesterol efflux from cultured fibroblasts. Regulation of low density lipoprotein receptor activity. , 1981, The Journal of biological chemistry.
[53] H. Brewer,et al. Coronary heart disease prevalence and other clinical features in familial high-density lipoprotein deficiency (Tangier disease). , 1980, Annals of internal medicine.